James Raley, MD
Surgery · Augusta, GANPI 1033592704
Payments from drug & device makers
Across 75 payments — averaging $176.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$8K
- Smith+Nephew$2K
- Johnson & Johnson$1K
- Zimmer Biomet$974
- Medacta USA, Inc.$458
- Stryker$309
- plus $373 from 8 others
What the payments were for
- Consulting fees$7,44056%
- Travel & lodging$1,81314%
- Food & beverage$3,99530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 15 | $8,440 |
| Smith+Nephew | 15 | $1,560 |
| Johnson & Johnson | 13 | $1,134 |
| Zimmer Biomet | 12 | $974 |
| Medacta USA, Inc. | 6 | $458 |
| Stryker | 6 | $309 |
| KCI USA, Inc. | 1 | $111 |
| AbbVie | 1 | $105 |
| Next Science LLC | 1 | $57 |
| Convatec Inc. | 1 | $24 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| Arthrosurface Incorporated | 1 | $22 |
| Globus Medical | 1 | $19 |
| Bioventus LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bioinductive Implant with Arthroscopic Delivery System - Medium$663
- Velys$344
- TRIGEN InterTAN$293
- GMK SPHERE$290
- Journey II$286
- Taperloc$256
- TFN-Advance$229
- PPK$214
- EVOS$150
- Journey II XR$138
- REAL INTELLIGENCE$138
- ROSA-Knee$135
- T2$128
- ATTUNE$128
- PREVENA$111
- AXSOS$110
- ROSA$109
- DALVANCE$105
How this compares
$13,248 in reported general payments places this provider in the 85th percentile of 855 surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 130 | $1,426 |
| Meloxicam | 459 | $1,316 |
| Tranexamic Acid | 18 | $1,169 |
| Pregabalin | 69 | $1,092 |
| Ondansetron Hcl | 108 | $972 |
| Methylprednisolone | 75 | $633 |
| Oxycodone Hcl | 137 | $587 |
| Tramadol Hcl | 126 | $584 |
| Pantoprazole Sodium | 105 | $545 |
| Dexamethasone | 108 | $418 |
| Celecoxib | 19 | $415 |
| Methocarbamol | 31 | $253 |
| Doxycycline Hyclate | 17 | $217 |
| Cefadroxil | 25 | $174 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $159 |
Paid to pharmacies, not to this prescriber.
Other surgery in Augusta
- Zachary KlaassenAugusta$763K
- Erika MabesAugusta$87K
- Chris CarlsonAugusta$73K
- Francisco JacomeAugusta$49K
- Idelberto BadellAtlanta$3.9M
- Chad CopperGainesville$999K
- Kendra GrubbAtlanta$761K
- Stephen OdomAustell$599K
- Fritz Jean-PierreMarietta$464K
- Nelson RoyallGainesville$415K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.